A negative outcome in this trial is more magnified than a positive one.
A new warning (on suicidal thoughts) could further add to pressure on the product.
The legal victory represents a significant reduction in the risk profile of the company. The company's fending off of this major threat is likely to lift sentiment for the entire large-cap pharmaceutical group through the remainder of 2005.
Drug companies have done a poor job managing public relations and they know this. In many cases, the individual drug companies have tried to set examples where they can. This is one area where Bristol has tried to set an example.
We believe that parents are very sensitive to safety issues for ADHD drugs and that a new warning could further add to pressure on the product.
Just because we have to study history doesn't mean we can't try to relate it to the current time. Once you start talking about something they're already up on, it draws them in.
They got slammed. The credibility of this company has been damaged and will continue to be so for some time until they can deliver.
Start settling the cases. I think taking this to the courtroom could be damaging. [Settlement] keeps the issue out of the courtroom and out of the media and it puts a lid on potential damages.
As potential patients, we would want these companies to make incremental improvements. Without it, we would end up only with first-in-class products that are not as good as they could be.
Copyright © 2024 Electric Goat Media. All Rights Reserved.